[Alpha-glucosidase inhibitor for type 2 diabetic patients. Clinical study with miglitol].
Fehmann
H C
HC
D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005944:Glucosamine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D050112:Imino Pyranoses; D007333:Insulin Resistance
D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D050112:Imino Pyranoses; C045621:miglitol; D017485:1-Deoxynojirimycin; D005944:Glucosamine
Alpha-Glukosidasehemmer für Typ 2 Diabetiker. Anwendungsbeobachtung mit Miglitol.